DOSSIER · 13F Holders · Q2 2025Healthcare · Biotechnology
2L9
BLUEPRINT MEDICINES CORP
5 institutions still hold BLUEPRINT MEDICINES CORP as of Q2 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 09627Y109·Biotechnology·5 13F holders·last filed Jun 30, 2025
AI Holders Summary · Q2 2025
5 institutions reported 2L9 in Q2 2025. NBW CAPITAL LLC leads at 99.3% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.